Previous Article | Next Article 
Journal of Virology, October 2001, p. 9345-9356, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9345-9356.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Localization to the Nucleolus Is a Common Feature of Coronavirus
Nucleoproteins, and the Protein May Disrupt Host Cell
Division
Torsten
Wurm,1
Hongying
Chen,1
Teri
Hodgson,1
Paul
Britton,2
Gavin
Brooks,3 and
Julian A.
Hiscox1,*
Virology Group1 and
Cardiovascular Cell Cycle Control
Group,3 School of Animal and Microbial Sciences,
University of Reading, Reading, Berkshire RG6 6AJ, and
Division of Molecular Biology, Institute for Animal Health,
Compton Laboratory, Compton, Newbury, Berkshire RG20
7NN,2 United Kingdom
Received 14 March 2001/Accepted 22 June 2001
 |
ABSTRACT |
The subcellular localization of transmissible gastroenteritis virus
(TGEV) and mouse hepatitis virus (MHV) (group I and group II
coronaviruses, respectively) nucleoproteins (N proteins) were examined
by confocal microscopy. The proteins were shown to localize either to
the cytoplasm alone or to the cytoplasm and a structure in the
nucleus. This feature was confirmed to be the nucleolus by using
specific antibodies to nucleolin, a major component of the nucleolus,
and by confocal microscopy to image sections through a cell expressing
N protein. These findings are consistent with our previous report for
infectious bronchitis virus (group III coronavirus) (J. A. Hiscox
et al., J. Virol. 75:506-512, 2001), indicating that nucleolar localization of the N protein is a common feature of the coronavirus family and is possibly of functional significance. Nucleolar localization signals were identified in the
domain III region of the N protein from all three coronavirus groups,
and this suggested that transport of N protein to the nucleus might be
an active process. In addition, our results suggest that the N protein
might function to disrupt cell division. Thus, we observed that
approximately 30% of cells transfected with the N protein appeared to
be undergoing cell division. The most likely explanation for this is
that the N protein induced a cell cycle delay or arrest, most
likely in the G2/M phase. In a fraction of
transfected cells expressing coronavirus N proteins, we observed multinucleate cells and dividing cells with nucleoli (which are only
present during interphase). These findings are consistent with the
possible inhibition of cytokinesis in these cells.
 |
INTRODUCTION |
Coronaviruses are enveloped RNA
viruses with nonsegmented, single-stranded, positive-sense RNA genomes
of 27 to 32 kb that are 5' capped and 3' polyadenylated
(26). The 5' two-thirds of the coronavirus genome encodes
the virus contribution to the replicase-transcription complex,
Rep1a and Rep1b, the latter resulting from a
1 frameshift
(8). During coronavirus replication, a 3'-coterminal
nested set of subgenomic mRNAs, which encode other viral proteins,
including nucleoprotein (N protein), are synthesized. In part, based on
similar genome replication strategies (17, 61), the
coronavirus family, Coronaviridae, has been grouped together
with the arterivirus family, Arteriviridae, into the order
Nidovirales (11). While gene functions and
distributions for the two families are similar, there are some
differences that might lead to subtle differences in replication
strategies. Recently, we have reported that the coronavirus
infectious bronchitis virus (IBV) N protein localizes to the
cytoplasm and a structure in the nucleus proposed to be the nucleolus
in both IBV-infected cells and cells transfected with a plasmid
expressing IBV N protein under the control of a PolII promoter
(23). A similar result was reported with the arterivirus
porcine reproductive and respiratory syndrome virus (PRRSV) N protein
(54), suggesting that localization of N protein to the
nucleolus was probably common to these two virus families and
potentially common to all Nidovirales.
Coronavirus replication is generally accepted to occur in the cytoplasm
of infected cells (66), although for IBV an intact cell
nucleus has been proposed to be necessary for virus replication (20). In addition, proteins normally associated with the
nucleus have been implicated in the replication of the murine
coronavirus mouse hepatitis virus (MHV) (30). The
nucleolus is a structure found within the nucleus and is only present
during interphase (1). It is the site where rRNA is
synthesized and where biogenesis of ribosomal subunits and polymerase
III transcripts occurs (10, 57). The nucleolus also
sequesters regulatory complexes and has been implicated in the
regulation of the cell cycle (10). The possible
involvement of the nucleolus in coronavirus replication is not
exclusive to coronaviruses. As a consequence of infection or a
deliberate process, a number of viruses, including adenoviruses (37) and poliovirus (65), redistribute
nucleolin, a major nucleolar antigen, from the nucleolus to the
cytoplasm. The nucleolus is the site of Borna disease virus replication
and transcription (50). A number of virus proteins have
been shown to localize to the nucleolus during virus infection
including human immunodeficiency virus type 1 Rev (18) and
Tat (59) and adenovirus V protein (38).
However, the possible role of the nucleolus in coronavirus replication
has not been elucidated, and why the N protein would localize to this
structure remains unknown. We hypothesized that the IBV N protein might
localize to the nucleolus as part of a virus strategy to control both
host cell and virus subgenomic RNA (sgRNA) translation by
associating with ribosomal subunits and that localization might be cell
cycle dependent (23). Furthermore, localization to the
nucleolus might be an intrinsic property of the coronavirus N protein.
Coronavirus N proteins vary from 377 to 455 amino acids in length, are
highly basic, and have a high (7 to 11%) serine content; serines are
potential targets for phosphorylation (29). Three groups of coronaviruses have been identified to date although sequence
conservation of the N proteins within the genus is low. For instance,
the N proteins of coronaviruses IBV (group III) and porcine
transmissible gastroenteritis virus (TGEV; group I) have only 29%
identity with that of bovine coronavirus (BCoV; group II) and, within
the group II coronaviruses, the N proteins of MHV and BCoV have only
70% identity (28). Based on amino acid sequence
comparisons, three structural domains in the coronavirus N protein have
been identified (45); of these, domain II was identified
as a potential RNA binding site (36, 41) capable of
binding both coronavirus- and non-coronavirus-derived RNA sequences in
vitro (36, 63), but it might also bind to viral RNAs with greater efficiency than nonviral RNAs (14). The possible
function(s) of domains I and III remains unknown. However, recently we
have identified a putative ribosome binding site motif and a putative nucleolar localization signal (NuLS) in domain III of the IBV Beaudette
N protein, a feature that was conserved in 10 other strains of IBV
(23).
Several functions have been postulated for the coronavirus N protein
throughout the virus life cycle (29). Primarily, it complexes with the genomic RNA to form a ribonucleocapsid structure (RNP) (16) and has been observed, together with the M
protein, to be a component of the viral core (19, 53). The
N protein has been shown to associate with the leader RNA sequence
(6, 42), located at the 5' end of the genomic RNA and/or
to sequences at the 3' end of the genomic RNA (68). As
these regions are believed to be involved in synthesis of coronavirus
RNA, the N protein has been postulated to have a role in replication of
the genomic RNA (12, 15), in the transcription of
coronavirus sgRNAs (6, 63), and in translation from the
sgRNAs (64). However, replication and transcription have
been shown to occur in the absence of N protein in arterivirus equine
arteritis virus (39). Although the N protein might not be
essential for coronavirus replication, the possibility that it may
still be involved in the efficiency of replication cannot be
discounted. The N protein may have multiple functions during virus
replication. Given that amino acid sequence conservation within the N
protein of the three different coronavirus groups is low, the fact that
N proteins from group I and group II coronaviruses also localize to the
nucleolus suggests that nucleolar localization may be of
functional significance. Accordingly, we investigated whether nucleolar
localization is a conserved feature among coronavirus N proteins and
determined the consequences of N protein expression on host cell
proliferation. Our results show that association with the nucleolus
is a common feature of the N proteins from the order
Nidovirales. In addition, expression of N protein leads to
an inhibition of host cell proliferation and concomitant polyploidy
in some cells, consistent with an inhibition of cytokinesis.
 |
MATERIALS AND METHODS |
Cells.
LLC-Pk1 cells were grown in Eagle minimum essential
medium supplemented with 10% fetal calf serum (FCS) at 37°C. Vero
and L cells were maintained in Dulbecco's modified Eagle's medium with Glutamax-I (Gibco) supplemented with 5% FCS at 37°C. Sf9 cells
were cultured in Sf-900II serum-free medium (Gibco BRL) at
28°C.
Transfection.
Mammalian cells (105 per
9.6-cm2 dish) were grown on glass coverslips and
were transfected with 2 µg of plasmid DNA and 16 µg of
Lipofectamine in Opti-MEM (Gibco) for 5 h; the medium was
replaced with maintenance medium for 24 h prior to fixing
with 50% methanol-50% acetone. Coverslips then were incubated for
1 h at 37°C with the appropriate primary antibody (detailed in
the text), washed for 10 min in excess phosphate-buffered saline
(PBS), reacted with a secondary antibody at a 1:100 dilution (see
below), and washed for 10 min in excess PBS. Fluorescent images were
viewed with a Leica confocal microscope.
Oligonucleotides.
The oligonucleotides used in this study
were obtained from MWG-Biotech and are listed in Table
1.
Recombinant DNA techniques.
Procedures for recombinant DNA
techniques were either standard (5, 56) or performed
according to the manufacturer's instructions.
PCR.
PCRs were carried out with a mixture containing 50 mM
KCl, 10 mM Tris-HCl (pH 9.0), 3.0 mM MgCl2, 10 pmol of each primer, 0.001 µg of template DNA, 0.25 mM
deoxynucleoside triphosphate, and 2.5 U of Taq polymerase
(Gibco BRL). The reaction was carried out in a total volume of 50 µl.
The reaction conditions were 94°C for 1 min, 65°C for 1 min, and
72°C for 1.5 min for 30 cycles. The last (extension) cycle was at
72°C for 6 min.
Recombinant plasmids.
The MHV N gene was produced by PCR,
using Taq polymerase, from a plasmid containing an authentic
copy of the MHV (JHM strain) N gene (pTR31) (55) using oligonucleotides
MHVJHMN5' (corresponding to XhoI and the N gene
start site) and MHVJHMN3' (corresponding to EcoRI
and the N gene stop site) and cloned into pCR-2.1 Topo (Invitrogen).
The MHV N gene was excised by digestion with XhoI and
EcoRI and cloned into pCi-Neo (Promega) that had been
digested with XhoI and EcoRI, creating pCi-MHV-N,
such that transcription of the MHV N gene was under the control of the
cytomegalovirus (CMV) promoter; the sequence was confirmed in
accordance with standard procedures. The TGEV N gene (strain FS772) was
cloned into pCi-Neo in a manner similar to that for the MHV N gene
using oligonucleotides TGEVNXho (corresponding to
XhoI and the N gene start site) and TGEVNNot
(corresponding to NotI and the N gene stop site),
creating pCi-TGEV-N. Additionally, the TGEV N gene (strain FS772) was
cloned directly into pCDNA4/HisMax (Invitrogen) using oligonucleotides
TGEVNXho and TGEVNNot, such that the TGEV N
protein was C-terminal of a His tag, creating pHis-TGEV-N. The sequence
and orientation of the insert were confirmed by restriction digestion
and sequencing (data not shown).
To synthesize recombinant IBV N protein, the IBV N gene was cloned into
pTriEx1.1 (Novagen). Oligonucleotide IBVNNco, corresponding
to the 5' end of the gene including the start codon, and an
NcoI
site were introduced at the 5' end of the coding
sequence. The
stop codon of the IBV N protein was deleted
using oligonucleotide
IBVN

stop, which was
complementary to the 3' end of the coding
sequence, and a
HindIII site was introduced. The IBV N gene was
amplified by PCR from pIBV322, which contains the Beaudette strain
N
gene (
7). pTriExIBVN was created by inserting the PCR
product
into
NcoI/
HindIII-restricted
pTriEx1.1 so that, in the resulting
construct, the gene would be
expressed with a His tag and a herpes
simplex virus tag fused to
the C
terminus.
Construction of recombinant baculovirus expressing the IBV N
protein.
Recombinant virus BacIBVN was generated by homologous
recombination after cotransfection of pTriExN together with
BacVector-3000 triple-cut virus DNA (Novagen). Baculoviruses were grown
in Sf9 cells. Potential recombinant viruses were plaque purified and amplified, and the N protein was detected by Western blotting (data not shown).
Transduction of mammalian cells with baculovirus.
Vero cells
(5 × 105 cells/well) were plated in
35-mm-diameter dishes and incubated overnight at 37°C in a
CO2 incubator. Baculoviruses were diluted in
growth medium (Dulbecco's modified Eagle's medium-10% FCS). Vero
cells were incubated with diluted virus at a multiplicity of infection
of 100 at 37°C for 2 h in a CO2 incubator.
After transduction, the cells were incubated for a further 22 h in
fresh growth medium and then fixed and assayed by indirect immunofluorescence.
Determination of cell division.
Normal, nontransfected Vero
cells and cells transfected with the appropriate construct expressing
the N protein were grown on coverslips as described above and fixed
with 50% methanol-50% acetone prior to staining with propidium
iodide (PI) to visualize nuclear material. The number of cells
undergoing cytokinesis or mitosis (cell division) was determined by
fluorescence microscopy by counting >100 transfected cells in three
different visual fields per slide.
 |
RESULTS |
Intracellular localization of the MHV and TGEV N proteins.
We
previously have shown that the IBV N protein can localize both to the
cytoplasm and the nucleolus in both IBV-infected cells and cells
transfected with a vector expressing the N protein under the control of
a CMV (PolII) promoter (23). To investigate whether
localization to both the cytoplasm and nucleolus is a feature common to
the N proteins of type I and type II coronaviruses, we cloned TGEV
(strain FS772; type I) and MHV (strain JHM; type II) N proteins into
eukaryotic expression vector pCi-Neo. In these constructs,
transcription of the N genes was placed under the control of a CMV
promoter such that translation of the resultant mRNA transcripts would
generate authentic coronavirus N proteins. These plasmids
were transfected into both species-specific cells (porcine LLC-PK1
cells for TGEV N and mouse L cells for MHV N) and non-species-specific
cells (Vero-monkey cells). Cells were incubated at 37°C for
24 h and fixed for analysis by indirect immunofluorescence using
mouse monoclonal anti-MHV N protein sera or mouse monoclonal anti-TGEV
N sera (DA3) (3), followed by fluorescein isothiocyanate
(FITC)-labeled goat anti-mouse antibody (Harlan Sera-Lab). Fixed cells
were then stained with PI to visualize nuclear DNA and analyzed by
confocal microscopy (Fig. 1). The TGEV
(Fig. 1A and B) and MHV (Fig. 1C and D) N proteins, expressed from
pCi-TGEV-N or pCi-MHV-N, respectively, were distributed throughout the cytoplasm alone or the cytoplasm and a structure in the
nucleus identified as the nucleolus. These results were identical to
those previously described for the localization of the IBV Beaudette N
protein in Vero cells (23). IBV Beaudette has been adapted for growth in Vero cells, and nucleolar localization of the N protein
in both species-specific and nonspecific cells indicates that nucleolar
localization is a common feature of all coronavirus N proteins.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 1.
Indirect detection of TGEV (A and B) and MHV (C and D) N
proteins in transfected cells and the IBV (E) N protein in transduced
cells by immunofluorescence. LLC-PK1 cells (A), L cells (C), and Vero
cells (B and D) were transfected with either pCi-TGEV-N or pCi-MHV-N or
were transduced with BacIBVN (E). They were incubated for 24 h,
fixed, and analyzed by indirect immunofluorescence using appropriate
antibodies (green) (see text). Additionally, cells were stained with PI
to directly visualize nuclear DNA (red). Differentially fluorescing
images were gathered separately from the same 0.5-µm-thick optical
section by using a confocal microscope and the appropriate filter. The
two images were digitally superimposed to depict the
distribution of the appropriate coronavirus N protein and nuclear DNA.
Arrow, position of a nucleolus. Magnifications, ×62 (A to D) and ×16
(2.73 zoom) (E).
|
|
Nucleolar localization of the coronavirus N protein is not an
artifact of the plasmid-based expression system.
The expression of
the MHV and TGEV N proteins and that previously described for IBV
(23) relied on the transfection of mammalian cells with a
plasmid that expressed the N gene under the control of a CMV promoter.
In addition, we have previously shown that the IBV N protein localizes
to the nucleolus in infected cells (23). While the
plasmid-based expression system has several advantages for studying
subtle phenotypes of the N protein, which may be masked in the context
of a virus-infected cell, we wanted to eliminate the possibility that
nucleolar localization was an artifact of the expression system.
Therefore we studied the localization of the N protein in a
non-plasmid-based system. The IBV N protein was cloned into the
NcoI and HindIII sites of pTriEx1.1
(Novagen), creating pTriExIBVN, such that expression of the IBV N
protein was under the control of the chicken
-actin promoter. This
vector contained baculovirus sequences flanking the cloning site, which permitted the generation of a recombinant baculovirus using the BacVector-3000 vector (Novagen), creating BacIBVN. Vero cells were
transduced with BacIBVN and incubated at 37°C for 24 h prior to
fixing and staining with polyclonal sera against IBV as
described previously (23). The IBV N protein expressed
from BacIBVN localized to both the cytoplasm and the nucleolus (Fig.
1E), identical to the pattern observed in cells either infected with
IBV or transfected with a plasmid expressing the IBV N protein
(23). Thus localization of the coronavirus N protein to
the nucleolus could not be attributed to either transfection or the
plasmid-based expression system and therefore was an intrinsic property
of the N protein itself.
Identification of the nucleolus.
The eukaryotic nucleus
contains a number of domains or subcompartments, which include
nucleoli, nuclear Cajal bodies (CBs), nuclear speckles, transcription
and replication foci, and chromosome territories (27). The
subnuclear structure identified in Fig. 1 and in our previous study
(23) is consistent with the nucleolus, in that
localization of the IBV N protein was observed only in cells that were
in interphase (when nucleoli are present) (1). However, to confirm that
this structure was located in the nucleus rather than being an artifact
located in the cytoplasm, Vero cells were transfected with pCi-TGEV-N
and incubated at 37°C for 24 h and fixed for analysis by
indirect immunofluorescence using mouse monoclonal DA3, specific to the
TGEV N protein, followed by a FITC-labeled goat anti-mouse
antibody (Harlan Sera-Lab). The fixed cells were stained with PI and
analyzed by confocal microscopy by taking nine 0.1-µm-thick
sections through a cell where the TGEV N protein localized to
both the cytoplasm and nucleolus. The sectioned cell was identified as
being in the G1 phase of the cell cycle as two
nucleoli were present in one nucleus (1) (Fig.
2A). Analysis of the various sections
(Fig. 2B) indicated that the structures preliminarily identified as
nucleoli were only present in the middle sections of the cell, in the
same focal plane as the nucleus, and thus are most likely within the
nucleus, rather than being an artifact in the cytoplasm or associated
with the cell (a similar result was observed in sections of Vero cells expressing the MHV N protein [data not shown]). To confirm
conclusively that this structure was the nucleolus, HeLa cells were
transfected with pCi-MHV-N, incubated at 37°C for 24 h, fixed,
and labeled with rabbit anti-MHV polyclonal sera followed by antirabbit
Alexa Fluor 564 (Molecular Probes) to visualize the MHV N protein and with mouse antinucleolin monoclonal sera (Leinco Laboratory) followed by a FITC-labeled goat anti-mouse antibody (Harlan Sera-Lab) to visualize the nucleolus. Nucleolin is a major nucleolus-specific protein (22, 58). Confocal microscopy indicated that the
MHV N protein localized to the structure in the nucleus that was
recognized by the antinucleolin antibody, which is consistent with the
structure being the nucleolus (Fig.
3).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of TGEV N proteins by indirect
immunofluorescence in transfected cells. Vero cells were transfected
with pCi-TGEV-N, incubated for 24 h, fixed, and analyzed by
indirect immunofluorescence using appropriate antibodies (green) (see
text). Additionally, cells were stained with PI to visualize nuclear
DNA (red). Differentially fluorescing images were gathered separately
from the same 0.5-µm-thick optical sections by using a confocal
microscope and the appropriate filter. The two images were digitally
superimposed to depict the distribution of TGEV N protein and
nuclear DNA (A). Arrow, position of a nucleolus. (B) The confocal
microscope was used to take 0.1-µm-thick sections of the cell shown
in panel A. The section on the top left is nearest the coverslip, and
the section on the bottom right is nearest the media. Magnification,
×62 (and ×2 zoom).
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
Detection of MHV N protein by indirect
immunofluorescence in transfected cells. HeLa cells were transfected
with pCi-MHV-N, incubated for 24 h, and analyzed by indirect
immunofluorescence using appropriate antibodies to detect the N protein
(red) and nucleolin (green) (see text). Differentially fluorescing
images were gathered separately from the same 0.5-µm-thick optical
section by using a confocal microscope and the appropriate filter. The
two images (A and B) were digitally superimposed to depict the
distribution of the MHV N protein and nucleolin (C). Yellow indicates
colocalization. Magnification, ×61.
|
|
Nucleolar localization of the N protein is not concentration
dependent.
Soluble proteins of less than approximately 60 kDa can
diffuse passively into the nucleoplasm through the nuclear pore complex and could in principle diffuse in and out of the nucleolar
compartment (52). However, nonsoluble nuclear
components are expected to become restricted to the nucleolus depending
on their binding sites (10). If nucleolar localization of
the N protein occurred randomly in a concentration-dependent
manner, then we would predict that transfected cells expressing more N
protein would have a greater number of nucleoli containing the N
protein. To investigate this, Vero cells were transfected with
pCi-MHV-N, incubated at 37°C for 24 h, and fixed for analysis by
indirect immunofluorescence using mouse monoclonal anti-MHV N protein
sera followed by a FITC-labeled goat anti-mouse antibody (Harlan
Sera-Lab). The fixed cells were stained with PI to visualize nuclear
DNA and analyzed by confocal microscopy (Fig.
4). Assuming that the amount of
fluorescence from FITC is proportional to the amount of N protein in a
cell, then variations in N protein concentrations among cells can be compared. Comparison of cells with the N protein in the cytoplasm with
cells with the N protein in both the cytoplasm and nucleolus indicated
that nucleolar localization was not directly proportional to the amount
of N protein within the cell (Fig. 4). A similar result was observed in
cells expressing either the IBV N protein (Fig. 1E) or the TGEV N
protein (data not shown).

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 4.
Detection of MHV N proteins by indirect
immunofluorescence in transfected cells. Vero cells were transfected
with pCi-MHV-N, incubated for 24 h, fixed, and analyzed by
indirect immunofluorescence using appropriate antibodies (green) (see
text). Additionally, cells were stained with PI to visualize nuclear
DNA (red). Differentially fluorescing images were gathered separately
from the same 0.5-µm-thick optical sections by using a confocal
microscope and the appropriate filter. The two images were digitally
superimposed to depict the distribution of the MHV N protein and
nuclear DNA. Squares, cells in which the MHV N protein localized to the
cytoplasm; circles, cells where the MHV N protein localized to both the
cytoplasm and the nucleolus. Magnification, ×16.
|
|
MHV and TGEV N proteins contain putative nucleolar localization
signals and may associate with rRNA.
Several nuclear localization
signals (NLS) have been identified; these include the pat4 motif, which
consists of a continuous stretch of four basic amino acids (arginine or
lysine), and the pat7 sequence, which starts with a proline and which
is followed within three residues by a segment containing three basic
residues out of four (43). NuLSs are less well understood
but usually incorporate an NLS. Using these criteria, amino acid
sequence analysis indicated that TGEV N protein (amino acids 331 to
350; RPSEVAKEQRKRKSRSKSAE) has a potential pat4
motif (underlined) and that the MHV N protein (amino acids 381 to 400;
QDGGADVVSPKPQRKRGTK) has a potential pat7 motif
(underlined), both located in the third domain of the N protein. A
putative pat7 motif also was located in the domain III region of the
IBV Beaudette strain N protein (23). Thus, the
conservation of a putative NuLS in domain III of N proteins
representative of the three different coronavirus groups suggests that
it may be of functional significance.
The coronavirus N protein might affect cell division.
During
the course of this study, we observed that approximately 25 to 30% of
transfected Vero cells expressing the TGEV N protein at various time
points posttransfection were apparently undergoing cell division (Fig.
5A and B), unlike what is found in
mock-transfected cells (Table 2). Assuming that most mammalian cells, on average, take approximately
24 h to go through the cell cycle, with mitosis and cytokinesis
taking approximately 1 h, then in any 24-h period 4% of cells
would be expected to be dividing. This figure is in agreement with the
number of cells undergoing division in the mock-transfected cells (Fig.
5C; Table 2). Apart from an intrinsic property of the N protein, a
number of possibilities could account for this observation. First, the
backbone vector, pCi-Neo, contains a neomycin resistance gene under the
control of an simian virus 40 early promoter (Promega), and expression of neomycin could result in the observation of a greater proportion of
cells undergoing division. Second, expression of a foreign gene from
the CMV promoter could lead to a similar result. Third, the coronavirus
N protein is an RNA binding protein and binding of cellular RNAs could
disrupt normal cell division.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 5.
Detection of TGEV N proteins (A, B, and E) and influenza
B virus NP (F) by indirect immunofluorescence and detection of EGFP (D)
(all green) and cell nuclei (A to F) (red) by direct
immunofluorescence. Vero cells were transfected with either pCi-TGEV-N,
pCDNA3-NP, or pEGFP, incubated for 24 h, fixed, and analyzed by
indirect immunofluorescence using appropriate techniques (see text).
Additionally, cells were stained with PI to directly visualize nuclear
DNA. Differentially fluorescing images were gathered separately from
the same 0.5-µm-thick optical sections by using a confocal microscope
and the appropriate filter. The two images were digitally superimposed
to depict the distribution of the appropriate protein and nuclear DNA.
Magnification, ×62.
|
|
To test the above hypotheses, we transfected Vero cells with pEGFP
(which expressed enhanced green fluorescent protein (EGFP)
under
the control of a CMV promoter), pCDNA3-NP (which expressed
influenza B
virus nucleoprotein [NP] under the control of a CMV
promoter),
and pHis-TGEV-N, which expressed the TGEV N protein
with an N-terminal
His tag under the control of a CMV promoter
and which contained
the zeocin rather than the neomycin resistance
gene. Two of
the vectors, pEGFP and pCDNA3-NP, had the neomycin
resistance gene
in common with pCi-TGEV-N, so if expression of
neomycin led
to an increased number of cells undergoing cell division,
then this might be discriminated by using pHis-TGEV-N.
Expression
of EGFP also tested the hypothesis that expression of a
foreign
gene from a CMV promoter led to increased cell division.
Influenza
B virus N protein is a known RNA binding protein (
2,
25)
that localizes to the nucleus (
62). Expression
of this protein
tested the hypothesis that RNA binding disrupted the
cell
cycle.
Vero cells transfected with pEGFP and pCDNA3-NP were fixed after
24 h; EGFP expression was analyzed directly, and influenza
virus
NP was analyzed by indirect immunofluorescence with a mouse
anti-B
virus NP monoclonal antibody (MAS774b; Harlan Sera-Lab)
and an
anti-mouse immunoglobulin G-FITC conjugate. Both samples
were mounted
in PI to visualize nuclear DNA. Both EGFP and influenza
B virus NP were
distributed evenly between the cytoplasm and nucleus
(Fig.
5D and F,
respectively). An average of 3 cells out of 100
were observed to be
undergoing cell division in cells expressing
EGFP, whereas an average
of 5 cells out of 100 in cells expressing
influenza B virus NP were
undergoing division. The background
level of cell division in Vero
cells was established to be between
2 and 5% (Table
2), which was in
accordance with the predicted
number. From these results we conclude
that neither expression
of neomycin nor expression of a foreign gene
(EGFP gene) nor expression
of an RNA binding protein (NP) affected cell
division. This suggested
that an intrinsic property of the TGEV N
protein was responsible
for disrupting cell division in transfected
cells.
To confirm that the observation was not an artifact of expression of a
protein from the pCi-Neo vector, the TGEV N protein
was expressed in
Vero cells from a vector with a backbone different
from
pCi-TGEV-N, pHis-TGEV-N. Transfected cells were fixed at
24, 36, and 48 h posttransfection for analysis by indirect
immunofluorescence
using mouse monoclonal anti-TGEV N sera (DA3),
followed by a FITC-labeled
goat anti-mouse antibody (Harlan Sera-Lab)
(Fig.
5E). Fixed cells
were stained with PI and analyzed by confocal
microscopy. At all
time points analyzed, over 25% of the cells
transfected with pHis-TGEV-N
were observed to be undergoing mitosis
(Table
3); this is a result
similar to
that observed in cells transfected with pCi-TGEV-N.
 |
DISCUSSION |
Although the Arteriviridae and Coronaviridae
have considerable differences in virion architecture and genetic
complexity, they are very similar in replication strategy and genome
organization (17). The N proteins of the coronaviruses and
arteriviruses are different in size (50 and 14 kDa, respectively) and
in amino acid sequence; however, both are thought to play a major
role in the formation of the virus core. Any other similarities between the N proteins, such as in intracellular localization, could suggest an
important function of this protein that has been conserved between the
two virus families. Rowland et al. (54) found that the N
protein of PRRSV, an arterivirus, localized to both the cytoplasm and
nucleolus in a subpopulation of cells infected with PRRSV and in cells
transfected with vectors expressing the PRRSV N protein. Recently, we
described a similar observation with the IBV (group III) N protein
(23), and taken together with this study, where the N
proteins of both TGEV (group I) and MHV (group II) coronaviruses
localize to both the cytoplasm and nucleolus (Fig. 1) in both
species-specific and nonspecific cells, these data suggest that
localization of the N protein to the nucleolus may be of functional
significance in the order Nidovirales.
The mechanism by which the N protein localizes to the nucleolus was not
determined in this study. However, nuclear pore complexes allow the
passive transport in both directions between the cytoplasm and
nucleoplasm of ions, small molecules, and proteins with molecular masses up to 40 to 60 kDa (46). The transport of larger
proteins through the pore is an active process requiring ATP, and such proteins must contain suitable NLS (43, 52). Coronavirus N proteins from all three groups meet both criteria in that they are less
than 50 kDa in size and contain putative NLS (pat4 and pat7 motifs) and
might therefore be expected to enter the nucleus via both passive and
active routes. Our previously published work suggests that transport of
N proteins into the nucleus (and subsequently to the nucleolus) might,
in part, be an active process, as an IBV N-green fluorescent protein
fusion protein with a mass of 74 kDa (which would, therefore, not be
expected to diffuse into the nucleoplasm unless it contained an NLS)
localized to both the cytoplasm and nucleolus (23). Data
suggest that domains I and III of the N protein are dispensable for RNA
binding (36, 41). The putative NuLS identified within the
domain III region of the N protein in this and a previous study
(23) might be responsible for the active transport of the
N protein into the nucleus. It is feasible that the N protein might
then associate with rRNA in the nucleolus via the RNA binding domain
(domain II). The BCoV N protein has been shown to associate with rRNA (14).
NuLSs are not restricted to pat4 and pat7 motifs, and arginine or
lysine clusters may be sufficient or, conversely, may not be required
at all. For example, nucleolar localization of the Marek's disease
virus bZIP oncoprotein, MEQ, is mediated by an arginine-rich region
(34), whereas putative NuLSs could not be identified in
the adenovirus IVa2 gene product, which localizes to the nucleolus
(35). Therefore, an alternative possibility is that the
coronavirus N protein associates with cellular proteins that are
targeted to the nucleolus, such as fibrillarin (4) and
nucleolin (22, 58). Indeed, nucleolar components are
involved in ribosome biogenesis (13), and the N protein
might associate with preribosomal proteins synthesized in the cytoplasm
and might be imported into the nucleolus. Fibrillarin is associated
with CBs (60), and these move to and from nucleoli
(47). Adenovirus infection results in the redistribution
of fibrillarin, with a possibly effect on viral and host cell
translation (49). Similar to polio- or adenovirus
infection (65, 37) coronavirus infection might result in
the redistribution of nucleolar antigens.
The function of N protein in the nucleolus is unknown, and our
observations could be of an artifact that occurs as a consequence of
the N protein diffusing into the nucleus and associating with rRNA.
Alternatively, the N protein might play a role in the regulation of the
cell cycle, as proteins that associate with the nucleolus previously
have been implicated in cell cycle regulation (10). Interestingly, CDK2 and cyclin E localize to CBs in a cell
cycle-dependent manner (33). A further alternative is that
nucleolar localization of the N protein could be part of a general
virus strategy to sequester ribosomal subunits for preferential
translation of virus sgRNAs. Several other possibilities also exist
(23).
The coronavirus N protein probably has multiple functions during the
virus life cycle (29). Evidence presented here suggests that the coronavirus N protein also might function to inhibit cell
division. There are two possibilities to account for our observed data
that approximately 25% of cells transfected with the TGEV N protein
appear to be undergoing cell division: the N protein could cause
increased cellular proliferation and hence speed up mitosis or it could
induce cell cycle delay or arrest. Of these two possibilities, we favor
the latter scenario since a delay in mitosis and/or inhibition of
cytokinesis could lead to an accumulation of cells in the M phase of
the cell cycle and hence the appearance that a significant number of
cells are undergoing cell division. In a fraction of transfected cells
expressing coronavirus N proteins we observed multinucleate cells (data
not shown), consistent with the fact that cytokinesis has been
inhibited in these cells. This is not an unprecedented finding for
mammalian cells since terminally differentiated adult cardiac myocytes,
which lose the ability to divide as the heart develops, also are
multinucleated (see reference 31 for a review). In
addition, the "dividing" cell expressing the TGEV N protein in Fig.
5E has a nucleolus in each nucleus (nuclei are separated by a cleavage
furrow), indicating that this cell, with respect to the
nucleoli, is in interphase (nucleoli are absent in dividing cells
[1]). The mechanism by which cytokinesis is inhibited in
these cells is unknown at this time although it may involve a
down-regulation in the activity and expression of the CDC2-cyclin B
complex as is the case in mature cardiac myocytes (9). It
is feasible that such a mechanism is also responsible for the effects
of the N protein. Taken together, these data suggest that the N protein
causes aberrant cell division, although a possible link between
nucleolar localization of the N protein and cell cycle control is not
established in this study.
It is not unusual for viruses and viral proteins to interact with the
cell cycle machinery to promote virus replication; this is a common
feature of DNA viruses that replicate in the nucleus (44).
Retroviruses also disrupt the cell cycle; thus, human immunodeficiency
virus type 1 Vpr arrests cells in the G2 phase (24), resulting in an increase in virus production
(51). Altering the host cell cycle appears to be less
common in RNA viruses and has not been extensively described in the
literature. For the negative-strand RNA viruses, there are several
examples of control of the cell cycle. The reovirus nonstructural
protein
1s arrests cells in G2/M during
infection (48). Measles virus infection results in a
G0 block (40), and the paramyxovirus
and simian virus (SV) V protein prolong the cell cycle by
delaying cells in G1 and G2
(32). For positive-strand RNA viruses, the phenomenon of
interacting with the cell cycle machinery is less common. The hepatitis
C virus (HCV) NS5a protein has been reported to promote cell growth by
repressing transcription of the cyclin-dependent kinase inhibitor gene
encoding p21WAF1 (21). In
addition, the HCV core protein interacts with this protein
(67).
Lin and Lamb (32) postulated that enveloped viruses might
delay the cell cycle in order to promote suitable conditions for virus
assembly, especially if the virus life cycle is longer than the cell
cycle. Intercellular sites of assembly for enveloped viruses
include the Golgi and the endoplasmic reticulum, which are disrupted
during cell division. The N protein might, therefore, have a function
similar to that of the SV V protein, although coronavirus replication
is quicker than that of SV and shorter than the cell cycle. However, it
might be advantageous for a virus that by chance infected a cell in the
latter stages of the cell cycle to delay the onset of mitosis for as
long as possible. Alternatively, coronaviruses could also be
controlling the cell cycle in order to create an environment favorable
for the translation of virus sgRNAs. Translation of host proteins is
approximately 25% in cells arrested in the G2/M
phase or mitosis compared to that in interphase cells, because the
cap-binding protein loses the ability to bind to the cap structure.
Some cellular mRNAs whose encoded proteins are necessary during mitosis
contain internal ribosome entry site elements, presumably to
overcome the block in cap-dependent translation (55).
Coronavirus sgRNAs and genomic RNA are capped and polyadenylated, and
cap-dependent translation is believed to be responsible for translation
of all of the coronavirus proteins with the exception of the envelope
(E) protein, whose translation is possibly cap independent. The N
protein might therefore have the dual function of delaying the cell
cycle to promote intracellular conditions for virus assembly and also
sequestering ribosomes for translation of viral proteins.
 |
ACKNOWLEDGMENTS |
This work was in part supported by a BBSRC project grant
(45/S12883) to J.A.H. and grant CT950064 of the Fourth RTD Framework Program of the European Commission to P.B. T.W. was supported by
the Reading Endowment Trust Fund awarded to J.A.H.
We thank Stuart Siddell for the donation of plasmid pTR31 and the mouse
monoclonal antibody to MHV JHM N protein, Peter Rottier for the
donation of rabbit polyclonal sera to MHV-JHM N protein, and Wendy
Barclay and Mark Stevens for the donation of pCDNA3-NP. We thank Steve
Poutney for assistance with the confocal microscope, Ian Jones for help
and advice with purifying IBV N protein and the generation of
recombinant baculovirus, and Gail Lynagh for critically reviewing the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: School of Animal
and Microbial Sciences, University of Reading, Whiteknights, P.O. Box
228, Reading RG6 6AJ, England, United Kingdom. Phone: 44 (0)118 931 8893. Fax: 44 (0)118 931 0180. E-mail:
j.a.hiscox{at}reading.ac.uk.
 |
REFERENCES |
| 1.
|
Alberts, B.,
D. Bray,
J. Lewis,
M. Raff,
K. Roberts, and J. D. Watson.
1994.
Molecular biology of the cell, 3rd ed., p. 381-382.
Garland Publishing, New York, N.Y.
|
| 2.
|
Albo, C.,
A. Valencia, and A. Portela.
1995.
Identification of an RNA binding region within the N-terminal third of the influenza virus nucleoprotein.
J. Virol.
69:3799-3806[Abstract].
|
| 3.
|
Alonso, J. M. M.,
M. Balbin,
D. J. Garwes,
L. Enjuanes,
S. Gascon, and F. Parra.
1992.
Antigenic structure of transmissible gastroenteritis virus nucleoprotein.
Virology
188:168-174[CrossRef][Medline].
|
| 4.
|
Aris, J. P., and G. Blobel.
1991.
cDNA cloning and sequencing of human fibrillarin, a conserved nucleolar protein recognized by autoimmune antisera.
Proc. Natl. Acad. Sci. USA
88:931-935[Abstract/Free Full Text].
|
| 5.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1987.
Current protocols in molecular biology.
John Wiley and Sons, New York, N.Y.
|
| 6.
|
Baric, R. S.,
G. W. Nelson,
J. O. Fleming,
R. J. Deans,
J. G. Keck,
N. Casteel, and S. A. Stohlman.
1988.
Interactions between coronavirus nucleocapsid protein and viral RNAs: implications for viral transcription.
J. Virol.
62:4280-4287[Abstract/Free Full Text].
|
| 7.
|
Boursnell, M. E. G.,
M. M. Binns,
I. J. Foulds, and T. D. K. Brown.
1985.
Sequence of the nucleocapsid genes from two strains of avian infectious bronchitis virus.
J. Gen. Virol.
66:573-580[Abstract/Free Full Text].
|
| 8.
|
Brierley, I.,
M. E. G. Boursnell,
M. M. Binns,
B. Bilimoria,
V. C. Blok,
T. D. K. Brown, and S. C. Inglis.
1987.
An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV.
EMBO J.
6:3779-3785[Medline].
|
| 9.
|
Brooks, G.,
R. A. Poolman,
C. J. McGill, and J. M. Li.
1997.
Expression and activities of cyclins and cyclin dependent kinases in developing rat ventricular myocytes.
J. Mol. Cell. Cardiol.
29:2261-2271[CrossRef][Medline].
|
| 10.
|
Carmo-Fonseca, M.,
L. Mendes-Soares, and I. Campos.
2000.
To be or not to be in the nucleolus.
Nat. Cell Biol.
2:E107-E112[CrossRef][Medline].
|
| 11.
|
Cavanagh, D.
1997.
Nidovirales: a new order comprising Coronaviridae and Arteriviridae.
Arch. Virol.
142:629-633[Medline].
|
| 12.
|
Chang, R.-Y., and D. A. Brian.
1996.
cis requirement for N-specific protein sequence in bovine coronavirus defective interfering RNA replication.
J. Virol.
70:2210-2217.
|
| 13.
|
Chen, D., and S. Huang.
2001.
Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells.
J. Cell Biol.
153:169-176[Abstract/Free Full Text].
|
| 14.
|
Cologna, R.,
J. F. Sapgnolo, and B. Hogue.
2000.
Identification of nucleocapsid binding sites within coronavirus-defective genomes.
Virology
277:235-249[CrossRef][Medline].
|
| 15.
|
Compton, J. R.,
D. B. Rogers,
K. V. Holmes,
D. Fertsch,
J. Remenick, and J. J. McGowan.
1987.
In vitro replication of mouse hepatitis virus strain A59.
J. Virol.
61:1814-1820[Abstract/Free Full Text].
|
| 16.
|
Davies, H. A.,
R. R. Dourmashkin, and R. MacNaughton.
1981.
Ribonucleoprotein of avian infectious bronchitis virus.
J. Gen. Virol.
53:67-74[Abstract/Free Full Text].
|
| 17.
|
de Vries, A. A. F.,
M. C. Horzinek,
P. J. M. Rottier, and R. J. de Groot.
1997.
The genome organisation of the nidovirales: similarities and differences between arteri-, toro-, and coronaviruses.
Semin. Virol.
8:33-47[CrossRef].
|
| 18.
|
Dundr, M.,
G. H. Lena,
M. L. Hammarskjold,
D. Rekosh,
C. Helga-Maria, and M. O. Olson.
1995.
The roles of nucleolar structure and function in the subcellular localisation of the HIV-1 rev protein.
J. Cell Sci.
108:2811-2823[Abstract].
|
| 19.
|
Escors, D.,
J. Ortego,
H. Laude, and L. Enjuanes.
2001.
The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability.
J. Virol.
75:1312-1324[Abstract/Free Full Text].
|
| 20.
|
Evans, M. R., and R. W. Simpson.
1980.
The coronavirus avian infectious bronchitis virus requires the cell nucleus and host transcription factors.
Virology
105:582-591[CrossRef][Medline].
|
| 21.
|
Ghosh, A. K.,
R. Steele,
K. Meyer,
R. Ray, and R. B. Ray.
1999.
Hepatitis C virus NS5a protein modulates cell cycle regulatory genes and promotes cell growth.
J. Gen. Virol.
80:1179-1183[Abstract].
|
| 22.
|
Ginisty, H.,
H. Sicard,
B. Roger, and P. Bouvet.
1999.
Structure and functions of nucleolin.
J. Cell Sci.
112:761-772[Abstract].
|
| 23.
|
Hiscox, J. A.,
T. Wurm,
L. Wilson,
D. Cavanagh,
P. Britton, and G. Brooks.
2001.
The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus.
J. Virol.
75:506-512[Abstract/Free Full Text].
|
| 24.
|
Hrimech, M.,
X.-J. Yao,
P. E. Branton, and E. A. Cohen.
2000.
Human immunodeficiency virus type 1 Vpr-mediated G2 cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A.
EMBO J.
19:3956-3967[CrossRef][Medline].
|
| 25.
|
Kobayashi, M.,
T. Toyoda,
D. M. Adyshev,
Y. Azuma, and A. Ishihama.
1994.
Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding domain.
J. Virol.
68:8433-8436[Abstract/Free Full Text].
|
| 26.
|
Lai, M. M. C., and D. Cavanagh.
1997.
The molecular biology of coronaviruses.
Adv. Virus Res.
48:1-100.
|
| 27.
|
Lamond, A. I., and W. C. Earnshaw.
1998.
Structure and function in the nucleus.
Science
280:547-553[Abstract/Free Full Text].
|
| 28.
|
Lapps, W.,
B. G. Hogue, and D. A. Brian.
1987.
Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein gene.
Virology
157:47-57[CrossRef][Medline].
|
| 29.
|
Laude, H., and P. S. Masters.
1995.
The coronavirus nucleocapsid protein, p. 141-163.
In
S. G. Siddell (ed.), The coronaviridae. Plenum Press, New York, N.Y.
|
| 30.
|
Li, H.-P.,
X. Zhang,
R. Duncan,
L. Comai, and M. M. C. Lai.
1997.
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA.
Proc. Natl. Acad. Sci. USA
94:9544-9549[Abstract/Free Full Text].
|
| 31.
|
Li, J. M., and G. Brooks.
1999.
Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system potential targets for therapy?
Eur. Heart J.
20:406-420[Free Full Text].
|
| 32.
|
Lin, G. Y., and R. A. Lamb.
2000.
The paramyxovirus simian virus 5 V protein slows progression of the cell cycle.
J. Virol.
74:9152-9166[Abstract/Free Full Text].
|
| 33.
|
Liu, J.-L.,
M. B. Hebert,
Y. Ye,
D. J. Templeton,
H.-J. King, and A. G. Matera.
2000.
Cell cycle-dependent localization of the CDK2-cyclin E complex in Cajal (coiled) bodies.
J. Cell Sci.
113:1543-1552[Abstract].
|
| 34.
|
Liu, J.-L.,
L. F. Lee,
Y. Ye,
Z. Qian, and H.-J. King.
1997.
Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ.
J. Virol.
71:3188-3196[Abstract].
|
| 35.
|
Lutz, P.,
F. Puvion-Dutilleul,
Y. Lutz, and C. Kedinger.
1996.
Nucleoplasmic and nucleolar distribution of the adenovirus IVa2 gene product.
J. Virol.
70:3449-3460[Abstract].
|
| 36.
|
Masters, P. S.
1992.
Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus.
Arch. Virol.
125:141-160[CrossRef][Medline].
|
| 37.
|
Matthews, D. A.
2001.
Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm.
J. Virol.
75:1031-1038[Abstract/Free Full Text].
|
| 38.
|
Matthews, D. A., and W. C. Russell.
1998.
Adenovirus core protein V is delivered by the invading virus to the nucleolus of the infected cell and later in infection is associated with nucleoli.
J. Gen. Virol.
79:1031-1038.
|
| 39.
|
Molenkamp, R.,
H. van Tol,
B. C. D. Rozier,
Y. van der Meer,
W. J. M. Spaan, and E. J. Snijder.
2000.
The arterivirus replicase is the only viral protein required for genome replication and subgenomic mRNA transcription.
J. Gen. Virol.
81:2491-2496[Abstract/Free Full Text].
|
| 40.
|
Naniche, D.,
S. I. Reed, and M. B. A. Oldstone.
1999.
Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression.
J. Virol.
73:1894-1901[Abstract/Free Full Text].
|
| 41.
|
Nelson, G. W., and S. A. Stohlman.
1993.
Localization of the RNA-binding domain of mouse hepatitis virus nucleocapsid protein.
J. Gen. Virol.
74:1975-1979[Abstract/Free Full Text].
|
| 42.
|
Nelson, G. W.,
S. A. Stohlman, and S. M. Tahara.
2000.
High affinity interaction between nucleocapsid protein and leader/intergenic sequence of mouse hepatitis virus RNA.
J. Gen. Virol.
81:181-188[Abstract/Free Full Text].
|
| 43.
|
Nigg, E. A.,
P. A. Baeuerle, and R. Luhrmann.
1991.
Nuclear import-export: in search of signals and mechanisms.
Cell
66:15-22[CrossRef][Medline].
|
| 44.
|
Op De Beeck, A., and P. Caillet-Fauquet.
1997.
Viruses and the cell cycle, p. 1-19.
In
L. Meijer, S. Guidet, and M. Philippe (ed.), Progress in cell cycle research, vol. 3. Plenum Press, New York, N.Y.
|
| 45.
|
Parker, M. M., and P. S. Masters.
1990.
Sequence comparison of the N genes of 5 strains of the coronavirus mouse hepatitis-virus suggests a 3 domain-structure for the nucleocapsid protein.
Virology
179:463-468[CrossRef][Medline].
|
| 46.
|
Peters, R.
1986.
Fluorescence microphotolysis to measure nucleocytoplasmic transport and intracellular mobility.
Biochim. Biophys. Acta
864:305-359[Medline].
|
| 47.
|
Platani, M.,
I. Goldberg,
J. R. Swedlow, and A. I. Lamond.
2000.
In vivo analysis of Cajal body movement, separation, and joining in live human cells.
J. Cell Biol.
151:1561-1574[Abstract/Free Full Text].
|
| 48.
|
Poggioli, G. J.,
C. Keefer,
J. L. Connolly,
T. S. Dermody, and K. L. Tyler.
2000.
Reovirus-induced G2/M cell cycle arrest requires 1s and occurs in the absence of apoptosis.
J. Virol.
74:9562-9570[Abstract/Free Full Text].
|
| 49.
|
Puvion-Dutilleul, F., and M. E. Christensen.
1993.
Alterations of fibrillarin distribution and nucleolar ultrastructure induced by adenovirus infection.
Eur. J. Cell Biol.
61:168-176[Medline].
|
| 50.
|
Pyper, J. M.,
J. E. Clements, and M. C. Zink.
1998.
The nucleolus is the site of Borna disease virus RNA transcription and replication.
J. Virol.
72:7697-7702[Abstract/Free Full Text].
|
| 51.
|
Re, F.,
D. Braaten,
E. K. Franke, and J. Luban.
1995.
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.
J. Virol.
69:6859-6864[Abstract].
|
| 52.
|
Richardson, W. D.,
A. D. Mills,
S. M. Dilworth,
R. A. Laskey, and C. Dingwall.
1988.
Nuclear protein migration involves two steps: rapid binding at the nuclear envelope followed by slower translocation through nuclear pores.
Cell
52:655-664[CrossRef][Medline].
|
| 53.
|
Risco, C.,
I. M. Anton,
L. Enjuanes, and J. L. Carrascosa.
1996.
The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins.
J. Virol.
70:4773-4777[Abstract].
|
| 54.
|
Rowland, R. R.,
R. Kerwin,
C. Kuckleburg,
A. Sperlich, and D. A. Benfield.
1999.
The localisation of porcine reproductive and respiratory syndrome virus nucleocapsid protein to the nucleolus of infected cells and identification of a potential nucleolar localization signal sequence.
Virus Res.
64:1-12[CrossRef][Medline].
|
| 55.
|
Sachs, A. B.
2000.
Cell cycle-dependent translation initiation: IRES elements prevail.
Cell
101:243-245[CrossRef][Medline].
|
| 56.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 57.
|
Scheer, U., and R. Hock.
1999.
Structure and function of the nucleolus.
Curr. Opin. Cell Biol.
11:385-390[CrossRef][Medline].
|
| 58.
|
Schmidt-Zachmann, M. S., and E. A. Nigg.
1993.
Protein localization to the nucleolus: a search for targeting domains in nucleolin.
J. Cell Sci.
105:799-806[Abstract].
|
| 59.
|
Siomi, H.,
H. Shida,
H. M. Maki, and M. Hatanaka.
1990.
Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization.
J. Virol.
64:1803-1807[Abstract/Free Full Text].
|
| 60.
|
Snaar, S.,
K. Wiesmeijer,
A. G. Jochemsen,
H. J. Tanke, and R. W. Dirks.
2000.
Mutational analysis of fibrillarin and its mobility in living human cells.
J. Cell Biol.
151:653-662[Abstract/Free Full Text].
|
| 61.
|
Snijder, E. J., and J. J. M. Meulenberg.
1998.
The molecular biology of arteriviruses.
J. Gen. Virol.
79:961-979[Medline].
|
| 62.
|
Stevens, M. P., and W. S. Barclay.
1998.
The N-terminal extension of the influenza B virus nucleoprotein is not required for nuclear accumulation or the expression and replication of a model RNA.
J. Virol.
72:5307-5312[Abstract/Free Full Text].
|
| 63.
|
Stohlman, S. A.,
R. S. Baric,
G. N. Nelson,
L. H. Soe,
L. M. Welter, and R. J. Deans.
1988.
Specific interaction between coronavirus leader RNA and nucleocapsid protein.
J. Virol.
62:4288-4295[Abstract/Free Full Text].
|
| 64.
|
Tahara, S. M.,
T. A. Dietlin,
C. C. Bergmann,
G. W. Nelson,
S. Kyuwa,
R. P. Anthony, and S. A. Stohlman.
1994.
Coronavirus translational regulation: leader affects mRNA efficiency.
Virology
202:621-630[CrossRef][Medline].
|
| 65.
|
Waggoner, S., and P. Sarnow.
1998.
Viral ribonucleoprotein complex formation and nucleolar-cytoplasmic relocalization of nucleolin in poliovirus-infected cells.
J. Virol.
72:6699-6709[Abstract/Free Full Text].
|
| 66.
|
Wilhelmsen, K. C.,
J. L. Leibowitz,
C. W. Bond, and J. A. Robb.
1981.
The replication of murine coronaviruses in enucleated cells.
Virology
110:225-230[CrossRef][Medline].
|
| 67.
|
Yoshida, W. F.,
M. Takamatsu,
S. Ishido,
T. Fujita,
K. Oka, and H. Hotta.
2000.
Complex formation between hepatitis C virus core protein and p21/Waf1/Cip1/Sdi1.
Biochem. Biophys. Res. Commun.
273:479-484[CrossRef][Medline].
|
| 68.
|
Zhou, M. L.,
A. K. Williams,
S. I. Chung,
L. Wang, and E. W. Collisson.
1996.
Infectious bronchitis virus nucleocapsid protein binds RNA sequences in the 3' terminus of the genome.
Virology
217:191-199[CrossRef][Medline].
|
Journal of Virology, October 2001, p. 9345-9356, Vol. 75, No. 19
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.19.9345-9356.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zhou, B., Liu, J., Wang, Q., Liu, X., Li, X., Li, P., Ma, Q., Cao, C.
(2008). The Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cell Cytokinesis and Proliferation by Interacting with Translation Elongation Factor 1{alpha}. J. Virol.
82: 6962-6971
[Abstract]
[Full Text]
-
Xie, M., Kobayashi, I., Kiyoshima, T., Yamaza, H., Honda, J.-y., Takahashi, K., Enoki, N., Akamine, A., Sakai, H.
(2007). Functional Implication of Nucleolin in the Mouse First Molar Development. J. Biol. Chem.
282: 23275-23283
[Abstract]
[Full Text]
-
Reed, M. L., Howell, G., Harrison, S. M., Spencer, K.-A., Hiscox, J. A.
(2007). Characterization of the Nuclear Export Signal in the Coronavirus Infectious Bronchitis Virus Nucleocapsid Protein. J. Virol.
81: 4298-4304
[Abstract]
[Full Text]
-
Boyne, J. R., Whitehouse, A.
(2006). Nucleolar trafficking is essential for nuclear export of intronless herpesvirus mRNA. Proc. Natl. Acad. Sci. USA
103: 15190-15195
[Abstract]
[Full Text]
-
Jayaram, H., Fan, H., Bowman, B. R., Ooi, A., Jayaram, J., Collisson, E. W., Lescar, J., Prasad, B. V. V.
(2006). X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation.. J. Virol.
80: 6612-6620
[Abstract]
[Full Text]
-
Grieger, J. C., Snowdy, S., Samulski, R. J.
(2006). Separate Basic Region Motifs within the Adeno-Associated Virus Capsid Proteins Are Essential for Infectivity and Assembly.. J. Virol.
80: 5199-5210
[Abstract]
[Full Text]
-
Dove, B., Brooks, G., Bicknell, K., Wurm, T., Hiscox, J. A.
(2006). Cell cycle perturbations induced by infection with the coronavirus infectious bronchitis virus and their effect on virus replication.. J. Virol.
80: 4147-4156
[Abstract]
[Full Text]
-
Weiss, S. R., Navas-Martin, S.
(2005). Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Microbiol. Mol. Biol. Rev.
69: 635-664
[Abstract]
[Full Text]
-
You, J., Dove, B. K., Enjuanes, L., DeDiego, M. L., Alvarez, E., Howell, G., Heinen, P., Zambon, M., Hiscox, J. A.
(2005). Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J. Gen. Virol.
86: 3303-3310
[Abstract]
[Full Text]
-
Rowland, R. R. R., Chauhan, V., Fang, Y., Pekosz, A., Kerrigan, M., Burton, M. D.
(2005). Intracellular Localization of the Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein: Absence of Nucleolar Accumulation during Infection and after Expression as a Recombinant Protein in Vero Cells. J. Virol.
79: 11507-11512
[Abstract]
[Full Text]
-
Calvo, E., Escors, D., Lopez, J. A., Gonzalez, J. M., Alvarez, A., Arza, E., Enjuanes, L.
(2005). Phosphorylation and subcellular localization of transmissible gastroenteritis virus nucleocapsid protein in infected cells. J. Gen. Virol.
86: 2255-2267
[Abstract]
[Full Text]
-
Jonassen, C. M., Kofstad, T., Larsen, I.-L., Lovland, A., Handeland, K., Follestad, A., Lillehaug, A.
(2005). Molecular identification and characterization of novel coronaviruses infecting graylag geese (Anser anser), feral pigeons (Columbia livia) and mallards (Anas platyrhynchos). J. Gen. Virol.
86: 1597-1607
[Abstract]
[Full Text]
-
Mori, Y., Okabayashi, T., Yamashita, T., Zhao, Z., Wakita, T., Yasui, K., Hasebe, F., Tadano, M., Konishi, E., Moriishi, K., Matsuura, Y.
(2005). Nuclear Localization of Japanese Encephalitis Virus Core Protein Enhances Viral Replication. J. Virol.
79: 3448-3458
[Abstract]
[Full Text]
-
Chen, H., Gill, A., Dove, B. K., Emmett, S. R., Kemp, C. F., Ritchie, M. A., Dee, M., Hiscox, J. A.
(2005). Mass Spectroscopic Characterization of the Coronavirus Infectious Bronchitis Virus Nucleoprotein and Elucidation of the Role of Phosphorylation in RNA Binding by Using Surface Plasmon Resonance. J. Virol.
79: 1164-1179
[Abstract]
[Full Text]
-
Chen, C.-J., Sugiyama, K., Kubo, H., Huang, C., Makino, S.
(2004). Murine Coronavirus Nonstructural Protein p28 Arrests Cell Cycle in G0/G1 Phase. J. Virol.
78: 10410-10419
[Abstract]
[Full Text]
-
Hoyt, C. C., Bouchard, R. J., Tyler, K. L.
(2004). Novel Nuclear Herniations Induced by Nuclear Localization of a Viral Protein. J. Virol.
78: 6360-6369
[Abstract]
[Full Text]
-
Chen, C.-J., Makino, S.
(2004). Murine Coronavirus Replication Induces Cell Cycle Arrest in G0/G1 Phase. J. Virol.
78: 5658-5669
[Abstract]
[Full Text]
-
Ning, Q., Lakatoo, S., Liu, M., Yang, W., Wang, Z., Phillips, M. J., Levy, G. A.
(2003). Induction of Prothrombinase fgl2 by the Nucleocapsid Protein of Virulent Mouse Hepatitis Virus Is Dependent on Host Hepatic Nuclear Factor-4alpha. J. Biol. Chem.
278: 15541-15549
[Abstract]
[Full Text]
-
Michienzi, A., Li, S., Zaia, J. A., Rossi, J. J.
(2002). A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc. Natl. Acad. Sci. USA
99: 14047-14052
[Abstract]
[Full Text]
-
Wootton, S. K., Rowland, R. R. R., Yoo, D.
(2002). Phosphorylation of the Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein. J. Virol.
76: 10569-10576
[Abstract]
[Full Text]
-
Chen, H., Wurm, T., Britton, P., Brooks, G., Hiscox, J. A.
(2002). Interaction of the Coronavirus Nucleoprotein with Nucleolar Antigens and the Host Cell. J. Virol.
76: 5233-5250
[Abstract]
[Full Text]
-
Tijms, M. A., van der Meer, Y., Snijder, E. J.
(2002). Nuclear localization of non-structural protein 1 and nucleocapsid protein of equine arteritis virus. J. Gen. Virol.
83: 795-800
[Abstract]
[Full Text]